Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Neoplasms of the CNS

Free Subscription Articles published in J Nucl Med Retrieve available abstracts of 18 articles: HTML format

Single Articles

September 2021
1. NIENHUIS PH, Antunes IF, Glaudemans AWJM, Jalving M, et al
   (18)F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.
   J Nucl Med. 2021 Sep 9. pii: jnumed.121.262368. doi: 10.2967/jnumed.121.262368.
   PubMed     Abstract available
   
   
   August 2021
2. BAG AK, Wing MN, Sabin ND, Hwang SN, et al
   [(11)C]-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence.
   J Nucl Med. 2021 Aug 26. pii: jnumed.120.261891. doi: 10.2967/jnumed.120.261891.
   PubMed     Abstract available
   
   
   
3. BRENDLE C, Maier C, Bender B, Schittenhelm J, et al
   Impact of (18)F-FET PET/MR on clinical management of brain tumor patients.
   J Nucl Med. 2021 Aug 5. pii: jnumed.121.262051. doi: 10.2967/jnumed.121.262051.
   PubMed     Abstract available
   
   
   July 2021
4. VONKEN EPA, Bruijnen RCG, Snijders TJ, Seute T, et al
   Intra-arterial administration boosts (177)Lu-HA-DOTATATE accumulation in salvage meningioma patients.
   J Nucl Med. 2021 Jul 22. pii: jnumed.121.262491. doi: 10.2967/jnumed.121.262491.
   PubMed     Abstract available
   
   
   May 2021
5. ZARAGORI T, Oster J, Roch V, Hossu G, et al
   (18)F-FDOPA PET for the non-invasive prediction of glioma molecular parameters: a radiomics study.
   J Nucl Med. 2021 May 20. pii: jnumed.120.261545. doi: 10.2967/jnumed.120.261545.
   PubMed     Abstract available
   
   
   
6. COLLET S, Guillamo JS, Berro DH, Chakhoyan A, et al
   Simultaneous mapping of vasculature, hypoxia and proliferation using DSC-MRI, (18)F-FMISO PET, and (18)F-FLT PET in relation to contrast enhancement in newly diagnosed glioblastoma.
   J Nucl Med. 2021 May 20. pii: jnumed.120.249524. doi: 10.2967/jnumed.120.249524.
   PubMed     Abstract available
   
   
   January 2021
7. JIMENEZ-FRANCO LD, Glatting G, Prasad V, Weber WA, et al
   Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in (177)Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment.
   J Nucl Med. 2021;62:92-98.
   PubMed     Abstract available
   
   
   November 2020
8. CECCON G, Lohmann P, Werner JM, Tscherpel C, et al
   Early treatment response assessment using (18)F-FET PET compared to contrast-enhanced MRI in glioma patients following adjuvant temozolomide chemotherapy.
   J Nucl Med. 2020 Nov 6. pii: jnumed.120.254243. doi: 10.2967/jnumed.120.254243.
   PubMed     Abstract available
   
   
   September 2020
9. GALLDIKS N, Abdulla DS, Scheffler M, Wolpert F, et al
   Treatment Monitoring of Immunotherapy and Targeted Therapy using (18)F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences.
   J Nucl Med. 2020 Sep 4. pii: jnumed.120.248278. doi: 10.2967/jnumed.120.248278.
   PubMed     Abstract available
   
   
   August 2020
10. MIRIAN C, Duun-Henriksen AK, Maier AD, Pedersen MM, et al
    Somatostatin receptor-targeted radiopeptide therapy in treatment-refractory meningioma: an individual patient data meta-analysis.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.249607. doi: 10.2967/jnumed.120.249607.
    PubMed     Abstract available
    
    
    
11. FILSS CP, Stegmayr C, Lohmann P, Galldiks N, et al
    Reply to: Flare phenomenon in O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas: potential contribution from postoperative ischemia.
    J Nucl Med. 2020 Aug 28. pii: jnumed.120.251819. doi: 10.2967/jnumed.120.251819.
    PubMed    
    
    
    July 2020
12. NABAVIZADEH SA, Nasrallah IM, Pryma DA
    Flare phenomenon in O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas: potential contribution from postoperative ischemia.
    J Nucl Med. 2020 Jul 9. pii: jnumed.120.251116. doi: 10.2967/jnumed.120.251116.
    PubMed    
    
    
    
13. TATEKAWA H, Hagiwara A, Yao J, Oughourlian TC, et al
    Voxel-Wise and Patient-Wise Correlation of (18)F-FDOPA PET, rCBV, and ADC in Treatment-Naive Diffuse Gliomas with Different Molecular Subtypes.
    J Nucl Med. 2020 Jul 9. pii: jnumed.120.247411. doi: 10.2967/jnumed.120.247411.
    PubMed     Abstract available
    
    
    May 2020
14. KRAMER K, Donzelli M, Nwora E, Pandit-Taskar N, et al
    Assessing Cerebrospinal Fluid Flow Dynamics in Pediatric Patients with Central Nervous System Tumors Treated with Intraventricular Radioimmunotherapy.
    J Nucl Med. 2020;61:662-664.
    PubMed     Abstract available
    
    
    April 2020
15. HERHAUS P, Lipkova J, Lammer F, Yakushev I, et al
    CXCR4-targeted positron emission tomography imaging of central nervous system B-cell lymphoma.
    J Nucl Med. 2020 Apr 24. pii: jnumed.120.241703. doi: 10.2967/jnumed.120.241703.
    PubMed     Abstract available
    
    
    January 2020
16. FILSS CP, Schmitz AK, Stoffels G, Stegmayr C, et al
    Flare phenomenon in O-(2-[(18)F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas.
    J Nucl Med. 2020 Jan 31. pii: jnumed.119.238568. doi: 10.2967/jnumed.119.238568.
    PubMed     Abstract available
    
    
    September 2019
17. DE ZWART PL, van Dijken BR, Holtman GA, Stormezand GN, et al
    Diagnostic accuracy of positron emission tomography tracers for the differentiation of tumor progression from treatment-related changes in high-grade glioma: a systematic review and meta-analysis.
    J Nucl Med. 2019 Sep 20. pii: jnumed.119.233809. doi: 10.2967/jnumed.119.233809.
    PubMed     Abstract available
    
    
    January 2019
18. MARNER L, Nysom K, Sehested A, Borgwardt L, et al
    Early Postoperative (18)F-FET PET/MRI for Pediatric Brain and Spinal Cord Tumors.
    J Nucl Med. 2019 Jan 25. pii: jnumed.118.220293. doi: 10.2967/jnumed.118.220293.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: